Laboratorios Farmaceuticos ROVI SA
XBER:41L
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Laboratorios Farmaceuticos ROVI SA
XBER:41L
|
ES |
Wall St Price Targets
41L Price Targets Summary
Laboratorios Farmaceuticos ROVI SA
According to Wall Street analysts, the average 1-year price target for 41L is 91.1 EUR with a low forecast of 72.46 EUR and a high forecast of 117.33 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 41L's stock price target?
Price Target
91.1
EUR
According to Wall Street analysts, the average 1-year price target for 41L is 91.1 EUR with a low forecast of 72.46 EUR and a high forecast of 117.33 EUR.
What is the Revenue forecast for Laboratorios Farmaceuticos ROVI SA?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 5 years is 9%.
What is the Gross Profit forecast for Laboratorios Farmaceuticos ROVI SA?
Projected CAGR
12%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 5 years is 12%.
What is the Operating Income forecast for Laboratorios Farmaceuticos ROVI SA?
Projected CAGR
16%
Over the last 14 years, the compound annual growth rate for Operating Income has been 18%. The projected CAGR for the next 5 years is 16%.
What is the Pre-Tax Income forecast for Laboratorios Farmaceuticos ROVI SA?
Projected CAGR
20%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 18%. The projected CAGR for the next 3 years is 20%.
What is the Net Income forecast for Laboratorios Farmaceuticos ROVI SA?
Projected CAGR
15%
Over the last 14 years, the compound annual growth rate for Net Income has been 16%. The projected CAGR for the next 5 years is 15%.
